Cargando…
Diagnostic efficiency of whole-body (18)F-FDG PET/MRI, MRI alone, and SUV and ADC values in staging of primary uterine cervical cancer
BACKGROUND: The use of PET/MRI for gynecological cancers is emerging. The purpose of this study was to assess the additional diagnostic value of PET over MRI alone in local and whole-body staging of cervical cancer, and to evaluate the benefit of standardized uptake value (SUV) and apparent diffusio...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7821517/ https://www.ncbi.nlm.nih.gov/pubmed/33482909 http://dx.doi.org/10.1186/s40644-020-00372-5 |
_version_ | 1783639438887223296 |
---|---|
author | Steiner, Aida Narva, Sara Rinta-Kiikka, Irina Hietanen, Sakari Hynninen, Johanna Virtanen, Johanna |
author_facet | Steiner, Aida Narva, Sara Rinta-Kiikka, Irina Hietanen, Sakari Hynninen, Johanna Virtanen, Johanna |
author_sort | Steiner, Aida |
collection | PubMed |
description | BACKGROUND: The use of PET/MRI for gynecological cancers is emerging. The purpose of this study was to assess the additional diagnostic value of PET over MRI alone in local and whole-body staging of cervical cancer, and to evaluate the benefit of standardized uptake value (SUV) and apparent diffusion coefficient (ADC) in staging. METHODS: Patients with histopathologically-proven cervical cancer and whole-body (18)F-FDG PET/MRI obtained before definitive treatment were retrospectively registered. Local tumor spread, nodal involvement, and distant metastases were evaluated using PET/MRI or MRI dataset alone. Histopathology or clinical consensus with follow-up imaging were used as reference standard. Tumor SUVmax and ADC were measured and SUVmax/ADC ratio calculated. Area under the curve (AUC) was determined to predict diagnostic performance and Mann-Whitney U test was applied for group comparisons. RESULTS: In total, 33 patients who underwent surgery (n = 23) or first-line chemoradiation (n = 10) were included. PET/MRI resulted in higher AUC compared with MRI alone in detecting parametrial (0.89 versus 0.73), vaginal (0.85 versus 0.74), and deep cervical stromal invasion (0.96 versus 0.74), respectively. PET/MRI had higher diagnostic confidence than MRI in identifying patients with radical cone biopsy and no residual at hysterectomy (sensitivity 89% versus 44%). PET/MRI and MRI showed equal AUC for pelvic nodal staging (both 0.73), whereas AUC for distant metastases was higher using PET/MRI (0.80 versus 0.67). Tumor SUVmax/ADC ratio, but not SUVmax or ADC alone, was significantly higher in the presence of metastatic pelvic lymph nodes (P < 0.05). CONCLUSIONS: PET/MRI shows higher accuracy than MRI alone for determining local tumor spread and distant metastasis emphasizing the added value of PET over MRI alone in staging of cervical cancer. Tumor SUVmax/ADC ratio may predict pelvic nodal involvement. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40644-020-00372-5. |
format | Online Article Text |
id | pubmed-7821517 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-78215172021-01-22 Diagnostic efficiency of whole-body (18)F-FDG PET/MRI, MRI alone, and SUV and ADC values in staging of primary uterine cervical cancer Steiner, Aida Narva, Sara Rinta-Kiikka, Irina Hietanen, Sakari Hynninen, Johanna Virtanen, Johanna Cancer Imaging Research Article BACKGROUND: The use of PET/MRI for gynecological cancers is emerging. The purpose of this study was to assess the additional diagnostic value of PET over MRI alone in local and whole-body staging of cervical cancer, and to evaluate the benefit of standardized uptake value (SUV) and apparent diffusion coefficient (ADC) in staging. METHODS: Patients with histopathologically-proven cervical cancer and whole-body (18)F-FDG PET/MRI obtained before definitive treatment were retrospectively registered. Local tumor spread, nodal involvement, and distant metastases were evaluated using PET/MRI or MRI dataset alone. Histopathology or clinical consensus with follow-up imaging were used as reference standard. Tumor SUVmax and ADC were measured and SUVmax/ADC ratio calculated. Area under the curve (AUC) was determined to predict diagnostic performance and Mann-Whitney U test was applied for group comparisons. RESULTS: In total, 33 patients who underwent surgery (n = 23) or first-line chemoradiation (n = 10) were included. PET/MRI resulted in higher AUC compared with MRI alone in detecting parametrial (0.89 versus 0.73), vaginal (0.85 versus 0.74), and deep cervical stromal invasion (0.96 versus 0.74), respectively. PET/MRI had higher diagnostic confidence than MRI in identifying patients with radical cone biopsy and no residual at hysterectomy (sensitivity 89% versus 44%). PET/MRI and MRI showed equal AUC for pelvic nodal staging (both 0.73), whereas AUC for distant metastases was higher using PET/MRI (0.80 versus 0.67). Tumor SUVmax/ADC ratio, but not SUVmax or ADC alone, was significantly higher in the presence of metastatic pelvic lymph nodes (P < 0.05). CONCLUSIONS: PET/MRI shows higher accuracy than MRI alone for determining local tumor spread and distant metastasis emphasizing the added value of PET over MRI alone in staging of cervical cancer. Tumor SUVmax/ADC ratio may predict pelvic nodal involvement. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40644-020-00372-5. BioMed Central 2021-01-22 /pmc/articles/PMC7821517/ /pubmed/33482909 http://dx.doi.org/10.1186/s40644-020-00372-5 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article Steiner, Aida Narva, Sara Rinta-Kiikka, Irina Hietanen, Sakari Hynninen, Johanna Virtanen, Johanna Diagnostic efficiency of whole-body (18)F-FDG PET/MRI, MRI alone, and SUV and ADC values in staging of primary uterine cervical cancer |
title | Diagnostic efficiency of whole-body (18)F-FDG PET/MRI, MRI alone, and SUV and ADC values in staging of primary uterine cervical cancer |
title_full | Diagnostic efficiency of whole-body (18)F-FDG PET/MRI, MRI alone, and SUV and ADC values in staging of primary uterine cervical cancer |
title_fullStr | Diagnostic efficiency of whole-body (18)F-FDG PET/MRI, MRI alone, and SUV and ADC values in staging of primary uterine cervical cancer |
title_full_unstemmed | Diagnostic efficiency of whole-body (18)F-FDG PET/MRI, MRI alone, and SUV and ADC values in staging of primary uterine cervical cancer |
title_short | Diagnostic efficiency of whole-body (18)F-FDG PET/MRI, MRI alone, and SUV and ADC values in staging of primary uterine cervical cancer |
title_sort | diagnostic efficiency of whole-body (18)f-fdg pet/mri, mri alone, and suv and adc values in staging of primary uterine cervical cancer |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7821517/ https://www.ncbi.nlm.nih.gov/pubmed/33482909 http://dx.doi.org/10.1186/s40644-020-00372-5 |
work_keys_str_mv | AT steineraida diagnosticefficiencyofwholebody18ffdgpetmrimrialoneandsuvandadcvaluesinstagingofprimaryuterinecervicalcancer AT narvasara diagnosticefficiencyofwholebody18ffdgpetmrimrialoneandsuvandadcvaluesinstagingofprimaryuterinecervicalcancer AT rintakiikkairina diagnosticefficiencyofwholebody18ffdgpetmrimrialoneandsuvandadcvaluesinstagingofprimaryuterinecervicalcancer AT hietanensakari diagnosticefficiencyofwholebody18ffdgpetmrimrialoneandsuvandadcvaluesinstagingofprimaryuterinecervicalcancer AT hynninenjohanna diagnosticefficiencyofwholebody18ffdgpetmrimrialoneandsuvandadcvaluesinstagingofprimaryuterinecervicalcancer AT virtanenjohanna diagnosticefficiencyofwholebody18ffdgpetmrimrialoneandsuvandadcvaluesinstagingofprimaryuterinecervicalcancer |